346 related articles for article (PubMed ID: 29593326)
1. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
[TBL] [Abstract][Full Text] [Related]
2. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
Li Y; Li L; Qin J; Wu J; Dai X; Xu J
Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis.
Tang YN; Ding WQ; Guo XJ; Yuan XW; Wang DM; Song JG
Nat Commun; 2015 Sep; 6():8230. PubMed ID: 26354229
[TBL] [Abstract][Full Text] [Related]
5. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
Choi YJ; Baek GY; Park HR; Jo SK; Jung U
PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
[TBL] [Abstract][Full Text] [Related]
6. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
8. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
Mohankumar K; Shrestha R; Safe S
Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
[TBL] [Abstract][Full Text] [Related]
10. Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.
Liu X; Zhang Y; Zhou GJ; Hou Y; Kong Q; Lu JJ; Zhang Q; Chen X
Toxicol Appl Pharmacol; 2020 Oct; 404():115179. PubMed ID: 32745479
[TBL] [Abstract][Full Text] [Related]
11. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
12. Nano nickel oxide promotes epithelial-mesenchymal transition through transforming growth factor β1/smads signaling pathway in A549 cells.
Chang X; Tian M; Zhang Q; Gao J; Li S; Sun Y
Environ Toxicol; 2020 Dec; 35(12):1308-1317. PubMed ID: 32681694
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
[TBL] [Abstract][Full Text] [Related]
16. PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.
Zhu N; Zhang XJ; Zou H; Zhang YY; Xia JW; Zhang P; Zhang YZ; Li J; Dong L; Wumaier G; Li SQ
Acta Pharmacol Sin; 2021 Aug; 42(8):1280-1287. PubMed ID: 33536603
[TBL] [Abstract][Full Text] [Related]
17. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
18. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.
Wu L; Han L; Zhou C; Wei W; Chen X; Yi H; Wu X; Bai X; Guo S; Yu Y; Liang L; Wang W
FEBS J; 2017 Sep; 284(18):3000-3017. PubMed ID: 28703907
[TBL] [Abstract][Full Text] [Related]
20. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
